Laboratorios Farmaceuticos Rovi
ROVI.MC
#2967
Rank
NZ$7.23 B
Marketcap
$141.44
Share price
-2.75%
Change (1 day)
65.83%
Change (1 year)

P/S ratio for Laboratorios Farmaceuticos Rovi (ROVI.MC)

P/S ratio as of November 2024 (TTM): 5.15

According to Laboratorios Farmaceuticos Rovi's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 8.36. At the end of 2024 the company had a P/S ratio of 5.71.

P/S ratio history for Laboratorios Farmaceuticos Rovi from 2020 to 2024

PS ratio at the end of each year

Year P/S ratio Change
20245.7148.96%
20233.8367.59%
20222.29-62.38%
20216.0814.86%
20205.29